Cefazolin as Prophylaxis in Surgery

Target Organisms and Spectrum of Activity

The American College of Surgeons recommends cefazolin as the first-choice antibiotic for most surgical procedures requiring prophylaxis, due to its effectiveness against gram-positive organisms, including Staphylococcus aureus and Streptococcus species, as well as some gram-negative bacteria 1

Multiple guidelines, including those from the American Society of Health-System Pharmacists, consistently recommend cefazolin as the first-choice antibiotic for most surgical procedures requiring prophylaxis, with high-quality evidence supporting its efficacy 1, 2
The Infectious Diseases Society of America recommends cefazolin as an effective alternative to vancomycin for preventing infections caused by methicillin-susceptible S. aureus and streptococci, with moderate-quality evidence 3

The American College of Surgeons recommends administering cefazolin within 60 minutes before incision, providing optimal tissue concentrations at the time of potential bacterial contamination, with high-quality evidence 3
The Society for Healthcare Epidemiology of America recommends re-dosing cefazolin if the procedure exceeds 4 hours, with moderate-quality evidence 4

The American Heart Association recommends cefazolin for cardiac and vascular surgery, with high-quality evidence 1, 2
The American Academy of Orthopaedic Surgeons recommends cefazolin for orthopedic surgery, including joint replacements, with high-quality evidence 1, 2

The American Society of Health-System Pharmacists recommends standard dosing of 2g IV for most adult patients, with weight-based adjustments, with high-quality evidence 3, 4
The Obesity Society recommends higher doses (4g) for bariatric surgery patients, with moderate-quality evidence 4

The American College of Surgeons notes that cefazolin has a better safety profile compared to broader-spectrum antibiotics, with moderate-quality evidence 3

The Infectious Diseases Society of America recommends alternative agents like clindamycin or vancomycin for patients with true penicillin allergies, as the risk of developing an SSI increases by 50% when a second-line perioperative antibiotic is used, with high-quality evidence 3
The Society for Healthcare Epidemiology of America recommends adding vancomycin to cefazolin for optimal coverage in patients colonized with methicillin-resistant Staphylococcus aureus (MRSA), with moderate-quality evidence 3